Astellas Pharma Inc (4503.T)
4503.T on Tokyo Stock Exchange
Price Change (% chg)
Astellas Pharma Inc. is a Japan-based company mainly engaged in the pharmaceutical business. The Company is involved in the manufacture and sale of pharmaceutical products in Japan, the United States, Europe, China, Korea and Taiwan, through its subsidiaries. Its main products include immunosuppressive drug Prograf, overactive... (more)
|Market Cap (Mil.):||¥3,385,215.00|
|Shares Outstanding (Mil.):||2,259.82|
Earnings vs. Estimates
Analyst Research Reports
Astellas Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: MarketLine (a Datamonitor Company)
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.